Recruitment of a repressosome complex at the growth hormone receptor promoter and its potential role in diabetic nephropathy

Molecular and Cellular Biology

Volumn 23, Issue 3, 2003, Pages 815-825

  Gowri, P M ^a   Yu, J H ^a   Shaufl, A ^a   Sperling, M A ^a   Menon, R K ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; HISTONE; NUCLEAR FACTOR Y; NUCLEAR PROTEIN; PROTEIN; PROTEIN ACETYL H3; PROTEIN L2C1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BTEB1; TRANSCRIPTION FACTOR HMG Y; TRANSCRIPTION FACTOR I; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CHROMATIN; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; GENE EXPRESSION REGULATION; KIDNEY; MOLECULAR INTERACTION; MOLECULAR MODEL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALS; BASE SEQUENCE; CCAAT-BINDING FACTOR; CELL LINE; CHROMATIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DNA; DNA-BINDING PROTEINS; FEMALE; HMGA1A PROTEIN; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED NOD; MODELS, BIOLOGICAL; PROMOTER REGIONS (GENETICS); RECEPTORS, SOMATOTROPIN; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

ANIMALIA; MURINAE;

EID: 0037304683     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.3.815-825.2003     Document Type: Article

References (36)

1. Baxter, R. C., J. M. Bryson, and J. R. Turtle. 1980. Somatogenic receptors of rat liver: regulation by insulin. Endocrinology 107:1176-1181.
2. Bellush, L. L., S. Doublier, A. N. Holland, L. J. Striker, G. E. Striker, and J. J. Kopchick. 2000. Protection against diabetes-induced nephropathy in growth hormone receptor/binding protein gene-disrupted mice. Endocrinology 141:163-168.
3. Caretti, G., M. C. Motta, and R. Mantovani. 1999. NF-Y associates with H3-H4 tetramers and octamers by multiple mechanisms. Mol. Cell. Biol. 19:8591-8603.
4. Cheung, P., C. D. Allis, and P. Sassone-Corsi. 2000. Signaling to chromatin through histone modifications. Cell 103:263-271.
5. Currie, R. A. 1997. Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y). J. Biol. Chem. 272:30880-30888.
6. Currie, R. A. 1998. NF-Y is associated with the histone acetlytransferase GCN5 and P/CAF. J. Biol. Chem. 273:1430-1434.
7. de Cavanagh, E. M. V., F. Iinserra, J. Toblli, I. Stella, C. Fraga, and L. Ferder. 2001. Enalapril attenuates oxidative stress in diabetic rats. Hypertension 38:1130-1136.
8. Edens, A., and F. Talamantes. 1998. Alternative processing of growth hormone receptor transcripts. Endocr. Rev. 19:559-582.
9. Farsetti,A., M. Narducci, F. Moretti, S. Nanni, R. Mantovani,A. Sacchi, and A. Pontecorvi. 2001. Inhibition of ER alpha-mediated trans-activation of human coagulation factor XII gene by heteromeric transcription factor NF-Y. Endocrinology 142:3380-3388.
10. Gorski, K., M. Carneiro, and U. Schibler. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767-776.
11. Gugliucci, A., and M. Bendayan. 1995. Histones from diabetic rats contain increased levels of advanced glycation end products. Biochem. Biophys. Res. Commun. 212:56-62.
12. Izumi, H., C. Molander, L. Z. Penn, A. Ishisaki, K. Kohno, and K. Funa. 2001. Mechanism for the transcriptional repression by c-Myc on PDGF B-receptor. J. Cell. Sci. 114:1533-1544.
13. Jin, S., and K. W. Scotto. 1998. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell. Biol. 18:4377-4384.
14. Liberati, C., A. Ronchi, P. Lievens, S. Ottolenghi, and R. Mantovani. 1998. NF-Y organizes the Y-Globin CCAAT boxes region. J. Biol. Chem. 273: 16880-16889.
15. Liberati, C., R. Sgarra, G. Manifioletti, and R. Mantovani. 1998. DNA binding of NF-Y: the effect of HMG-I proteins depends upon the CCAAT box. FEBS Lett. 433:174-178.
16. Maity, S. N., and B. de Crombugghe. 1998. Role of the CCAAT-binding protein CBF/NF-Y in transcription. Trends. Biochem. Sci. 23:174-178.
17. Manni, I., G. Mazzaro, A. Gurtner, R. Mantovani, U. Haugwitz, K. Krause, K. Engeland, A. Sacchi, S. Soddu, and G. Piaggo. 2001. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest. J. Biol. Chem. 276:5570-5576.
18. Mantovani, R. 1999. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239:15-27.
19. Menon, R. K., S. Arslanian, B. May, W. S. Cutfield, and M. A. Sperling. 1992. Diminished growth hormone-binding protein in children with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 74:934-938.
20. Menon, R. K., A. Shaufl, J. H. Yu, D. A. Stephan, and R. P. Friday. 2001. Identification and characterization of a novel transcript of the murine growth hormone receptor gene exhibiting development- and tissue-specific expression. Mol. Cell. Endocrinol. 172:135-146.
21. Menon, R. K., D. A. Stephan, R. H. Rao, Z. Shen-orr, Jr., L. S. Down, C. T. Roberts, D. LeRoith, and M. A. Sperling. 1994. Tissue-specific regulation of the growth hormone receptor gene in streptozotocin-induced diabetes in the rat. J. Endocrinol. 142:453-462.
22. Menon, R. K., D. A. Stephan, M. Singh, S. M. Morris, Jr., and L. Zou. 1995. Cloning of the promoter-regulatory region of the murine growth hormone receptor gene: identification of a developmentally regulated enhancer element. J. Biol. Chem. 270:8851-8859.
23. Mercado, M., M. E. Molitch, and G. Baumann. 1992. Low plasma growth hormone binding protein in IDDM. Diabetes 41:605-609.
24. Munichoodappa, C. S., S. B. Rees, R. F. Bradley, M. C. Balodimos, and G. Boden. 1971. Bragg peak proton beam irradiation of the pituitary gland for proliferative diabetic retinopathy. Ann. Intern. Med. 74:491-498.
25. Munshi, N., M. Y. Merika, K. Senger, G. Chen, and D. Thanos. 1998. Acetylation of HMG-I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome. Mol. Cell 2:457-467.
26. Nakshatri, H., P. Bhat-Nakshatri, and R. A. Currie. 1996. Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J. Biol. Chem. 271:28784-28791.
27. Philipsen, S., and G. Suske. 1999. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 27:2991-3000.
28. Shi, Q., K. W. Gross, and C. D. Sigmund. 2001. NF-Y antagonizes renin enhancer function by blocking stimulatory transcription factors. Hypertension 38:332-336.
29. Smith, L. E., J. J. Kopchick, W. W. Chen, J. Knapp, F. Kinose, D. Daley, E. Foley, R. G. Smith, and J. M. Schaeffer. 1997. Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276:1706-1709.
30. Sonksen, P. H., D. Russell-Jones, and R. H. Jones. 1993. Growth hormone and diabetes mellitus. Horm. Res. 40:68-79.
31. Sterner, D. E., and S. L. Berger. 2000. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64:435-459.
32. Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403:41-45.
33. West, I. C. 2000. Radicals and oxidative stress in diabetes. Diabet. Med. 17:171-180.
34. Yu, J. H., G. Schwartzbauer, A. Kazlman, and R. K. Menon. 1999. Role of the Sp family of transcription factors in the ontogeny of growth hormone receptor gene expression. J. Biol. Chem. 274:34327-34336.
35. Zhang, J.-S., M. C. Moncrieffe, J. Kaczynski, V. Ellenrieder, F. G. Prendergast, and R. Urrutia. 2001. A conserved alpha-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol. Cell. Biol. 21:5041-5049.
36. Zou, L., and R. K. Menon. 1995. A member of the CTF/NF-1 transcription factor family regulates murine growth hormone receptor gene promoter activity. Endocrinology 136:5236-5239.